Check out the companies making headlines in premarket trading: Bristol-Myers Squibb — The biopharmaceutical stock jumped 5.3% after the U.S. Food and Drug Administration approved Cobenfy as a treatment of schizophrenia for adults. It marks the first new type of...
A shareholder at a securities hall in Hangzhou, the capital of Zhejiang province in east China, on Sept. 24, 2024.Cfoto | Future Publishing | Getty ImagesBEIJING — China’s latest policy signals have a bigger impact on sentiment than resolving deeper issues such...
Check out the companies making headlines in midday trading. Micron Technology , chip stocks — Shares surged nearly 15% after the memory chipmaker issued strong guidance as the rise of AI heightens demand for its products. Other chip stocks rose alongside, with Applied...
David Tepper, founder and president of Appaloosa Management.David Orrell | CNBCAppaloosa Management’s David Tepper said investors should believe the Federal Reserve when it says it will lower interest rates because the central bank has now to keep...
Billionaire hedge fund founder David Tepper said his big bet after the Federal Reserve’s rate cut was to buy Chinese stocks. “I thought that what the Fed did last week would lead to China easing, and I didn’t know that they were going to bring out...